[Left atrial appendage in rheumatic mitral valve disease: The main source of embolism in atrial fibrillation]
- PMID: 27986559
- DOI: 10.1016/j.acmx.2016.11.007
[Left atrial appendage in rheumatic mitral valve disease: The main source of embolism in atrial fibrillation]
Abstract
Objective: To demonstrate that surgical removal of the left atrial appendage in patients with rheumatic mitral valve disease and long standing persistent atrial fibrillation decreases the possibility of stroke. This also removes the need for long-term oral anticoagulation after surgery.
Method: A descriptive, prospective, observational study was conducted on 27 adult patients with rheumatic mitral valve disease and long standing persistent atrial fibrillation, who had undergone mitral valve surgery and surgical removal of the left atrial appendage. Oral anticoagulation was stopped in the third month after surgery. The end-point was the absence of embolic stroke. An assessment was also made of postoperative embolism formation in the left atrium using transthoracic echocardiography.
Results: None of the patients showed embolic stroke after the third post-operative month. Only one patient exhibited transient ischaemic attack on warfarin therapy within the three postoperative months. Left atrial thrombi were also found in 11 (40.7%) cases during surgery. Of these, 6 (54.5%) had had embolic stroke, with no statistical significance (P=.703).
Conclusions: This study suggests there might be signs that the left atrial appendage may be the main source of emboli in rheumatic mitral valve disease, and its resection could eliminate the risk of stroke in patients with rheumatic mitral valve disease and long-standing persistent atrial fibrillation.
Keywords: Atrial appendage; Atrial fibrillation; Atrial thrombus; Enfermedad reumática cardiaca; Fibrilación auricular; Mexico; Mitral valve; México; Orejuela; Rheumatic heart disease; Trombo auricular; Válvula mitral.
Copyright © 2016 Instituto Nacional de Cardiología Ignacio Chávez. Publicado por Masson Doyma México S.A. All rights reserved.
Similar articles
-
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.EuroIntervention. 2010 Jun;6(2):220-6. EuroIntervention. 2010. PMID: 20562072 Clinical Trial.
-
Left atrial appendage exclusion during mitral valve surgery and stroke in atrial fibrillation.J Interv Card Electrophysiol. 2018 Dec;53(3):285-292. doi: 10.1007/s10840-018-0458-4. Epub 2018 Sep 28. J Interv Card Electrophysiol. 2018. PMID: 30267182
-
Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: a transesophageal echocardiographic study.Indian Heart J. 2003 Jul-Aug;55(4):358-61. Indian Heart J. 2003. PMID: 14686666
-
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Rev Neurol (Paris). 2015. PMID: 25912470 Review.
-
Left atrial appendage closure.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):195-201. doi: 10.1016/j.pcad.2015.07.009. Epub 2015 Aug 1. Prog Cardiovasc Dis. 2015. PMID: 26241302 Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical